Legal Opinion
Hospira, Inc. v. Fresenius Kabi USA, LLC
District Court, E.D. Illinois
Decided December 17, 2018No. Nos. 16 C 651; 17 C 7903PublishedCited by 1 opinion
1Opinion of the Court
REBECCA R. PALLMEYER, DISTRICT JUDGE
Plaintiff Hospira, Inc., a Delaware corporation with its primary place of business in Illinois, manufactures pharmaceuticals and medical supplies. One of Hospira's products is a chemical compound known as dexmedetomidine, which Hospira sells to health care providers under the brand name Precedex. Between 2012 and 2014, Hospira obtained four patents covering a new product made from dexmedetomidine: U.S. Patent Nos. 8,242,158 (the " '158 Patent"), 8,338,470 (the " '470 Patent"), 8,455,527 (the " '527 Patent"), and 8,648,106 (the " '106 Patent"). (Complaint in…
2Cases cited31 opinions
- Graham v. John Deere Co. of Kansas CitySupreme Court of the United States · 1966
- KSR International Co. v. Teleflex Inc.Supreme Court of the United States · 2007
- Microsoft Corp. v. i4i Ltd. PartnershipSupreme Court of the United States · 2011
- Pfizer, Inc. v. Apotex, Inc.Court of Appeals for the Federal Circuit · 2007
- Telemac Cellular Corporation v. Topp Telecom, Inc.Court of Appeals for the Federal Circuit · 2001
26 more not listed; retrieve them via the Exa API.
3Cited by1 opinion
- Hospira, Inc. v. Fresenius Kabi USA, LLCCourt of Appeals for the Federal Circuit · 2020